Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis

We describe a case of prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a patient receiving ocrelizumab for multiple sclerosis. Viral RNA shedding, signs, and symptoms persisted for 69 days with resolution after administration of convalescent plasma and antiviral th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Open Forum Infect Dis
Hlavní autoři: Gibson, Elena G, Pender, Melissa, Angerbauer, Michael, Cook, Craig, Jones, Barbara, Spivak, Adam M, Spivak, Emily S, Swaminathan, Sankar
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2021
Témata:
Brief Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8083367/
https://ncbi.nlm.nih.gov/pubmed/34258310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab176
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky